[1] Morisseau C, Hammock BD. Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol. 2013;53(2):37-58. [2] 党海霞,霍欣茹,王福,等.14,15-环氧二十碳三烯酸促进颅骨缺损骨再生[J].口腔医学研究,2016,32(7):692-695.[3] Abdu E, Bruun DA, Yang D, et al. Epoxyeicosatrienoic acids enhance axonal growth in primary sensory and cortical neuronal cell cultures. J Neurochem. 2011;117(4): 632-642. [4] Sander AL, Jakob H, Sommer K, et al. Cytochrome P450-derived epoxyeicosatrienoic acids accelerate wound epithelialization and neovascularization in the hairless mouse ear wound model. Langenbecks Arch Surg. 2011;396(8): 1245-1253. [5] Panigrahy D, Kalish BT, Huang S, et al. Epoxyeicosanoids promote organ and tissue regeneration. Proc Natl Acad Sci U S A. 2013;110(33):13528-13533. [6] Vanella L, Kim DH, Sodhi K, et al. Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes. Prostaglandins Other Lipid Mediat. 2011;96(1):54-62. [7] Guan H, Zhao L, Cao H, et al. Epoxyeicosanoids suppress steoclastogenesis and prevent ovariectomy-induced bone loss. FASEB J. 2015;29(3):1092-1101. [8] Shahabi P, SiestG, Visvikis-siest S. cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids. Drug Metab Rev. 2014;46(1):33-56. [9] Buczynski MW, Dumlao DS, Dennis EA. Thematic review series: proteomics. An integrated omics analysis of eicosanoid biology. J Lipid Res. 2009;50(11):1015-1038. [10] Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294(5548):1871-1875. [11] Buch PR, Desai I, Balakrishnan S. COX-2 activity and expression pattern during regenerative wound healing of tail in lizard Hemidactylus flaviviridis. Prostaglandins Other Lipid Mediat. 2018;135:11-15. [12] Chiang N, Riley IR, Dalli J, et al. New maresin conjugates in tissue regeneration pathway counters leukotriene D4-stimulated vascular responses. FASEB J. 2018;32(7): 4043-4052. [13] He J, Wang C, Zhu Y, et al. Soluble epoxide hydrolase: A potential target for metabolic diseases. J Diabetes. 2015; 8(3):305-313. [14] Elshenawy OH, Anwar-Mohamed A, El-Kadi AO. 20-Hydroxyeicosatetraenoic acid is a potential therapeutic target in cardiovascular diseases. Curr Drug Metab. 2013; 14(6):706-719. [15] Hoopes SL, Garcia V, Edin ML, et al. Vascular actions of 20-HETE.Prostaglandins Other Lipid Mediat. 2015;120:9-16. [16] Imig JD. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function. Adv Pharmacol. 2016;77:105-141. [17] Garcia V, Schwartzman ML. Recent developments on the vascular effects of 20-hydroxyeicosatetraenoic acid. Curr Opin Nephrol Hypertens. 2017;26(2):74-82. [18] Swardfager W, Hennebelle M, Yu D, et al. Metabolic/ inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target. Neurosci Biobehav Rev. 201887:56-66. [19] Lee KS, Liu JY, Wagner KM, et al. Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy. J Med Chem. 2014;57(16):7016-7030. [20] Yu Z, Xu F, Huse LM, et al. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res. 2000;87(11):992-998. [21] Imig JD, Zhao X, Zaharis CZ, et al. An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension. 2005; 46(4):975-981. [22] Luria A, Bettaieb A, Xi Y, et al. Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance. Proc Natl Acad Sci U S A. 2011;108(22):9038-9043. [23] Fleming I. Vascular cytochrome p450 enzymes: physiology and pathophysiology. Trends Cardiovasc Med. 2008;18(1): 20-25. [24] Street J, Bao M, Bunting S, et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A. 2002;99(15): 9656-9661. [25] Folkman J. Angiogenesis: an organizing principle for drug discovery? . Nat Rev Drug Discov. 2007;6(4):273-286. [26] 鲍小刚,许国华.组织工程骨的快速血管化[J].中国组织工程研究,2015,19(7):1063-1069.[27] Zhang C, Harder DR. Cerebral capillary endothelial cell mitogenesis and morphogenesis induced by astrocytic epoxyeicosatrienoic acid. Stroke. 2002;33(12):2957-2964. [28] Capozzi ME, McCollum GW, Penn JS. The role of cytochrome P450 epoxygenases in retinal angiogenesis. Invest Ophthalmol Vis Sci. 2014;55(7):4253-4260. [29] Pulin Li, Jamie L, Lahvic, et al. Epoxyeicosatrienoic Acids Enhance Embryonic Haematopoiesis and Adult Marrow Engraftment. Nature. 2015;523(7561):468-471. [30] Tassi E, McDonnell K, Gibby KA, et al. Impact of fibroblast growth factor-binding protein–1 expression on angiogenesis and wound healing. Am J Pathol. 2011;179(5):2220-2232. [31] Cheranov SY, Karpurapu M, Wang D, et al. An essential role for SRC-activated STAT-3 in 14, 15-EET–induced VEGF expression and angiogenesis. Blood. 2008;111(12):5581-5591. [32] Michaelis UR, Fisslthaler B, Barbosa-Sicard E, et al. Cytochrome P450 epoxygenases t2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis. J Cell Sci. 2005;118(23):5489-5498. [33] Chen JK, Capdevila J, Harris RC. Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells. Proc Natl Acad Sci U S A. 2002;99(9):6029-6034. [34] Xu DY, Davis BB, Wang ZH. A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction. Int J Cardiol. 2013;167(4):1298-1304. [35] Revermann M, Schloss M, Barbosa-Sicard E. Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice. Arterioscler Thromb Vasc Biol. 2010;30(5):909-914. [36] Davis BB, Thompson DA, Howard LL. Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation. Proc Natl Acad Sci U S A. 2002;99(4):2222-2227. [37] Ng VY, Morisseau C, Falck JR, et al. Inhibition of smooth muscle proliferation by urea-based alkanoic acids via peroxisome proliferator-activated receptor alpha-dependent repression of cyclin D1. Arterioscler Thromb Vasc Biol. 2006; 26(11):2462-2468. [38] Kim HS, Kim SK, Kang KW. Differential Effects of sEH Inhibitors on the Proliferation and Migration of Vascular Smooth Muscle Cells. Int J Mol Sci. 2017;18(12):2683. [39] Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6(4):389-395. [40] Fleming I, Michaelis UR, Bredenkötter D, et al. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res. 2001; 88(1):44-51[41] Eming SA, Wynn TA, Martin P. Inflammation and metabolism in tissue repair and regeneration. Science. 2017;356(6342): 1026-1030. [42] Liu H, Li D, Zhang Y, et al. Inflammation, mesenchymal stem cells and bone regeneration. Histochem Cell Biol. 2018;149 (4): 393-404. [43] Runyan CM, Gabrick KS. Biology of Bone Formation, Fracture Healing, and Distraction Osteogenesis. J Craniofac Surg. 2017;28(5):1380-1389. [44] Chen FM, Lu H, Wu LA, et al. Surface-engineering of glycidyl methacrylated dextran/gelatin microcapsules with thermo-responsive poly(N-isopropylacrylamide) gates for controlled delivery of stromal cell-derived factor-1α. Biomaterials. 2013;34(27):6515-6527. [45] Godot V, Arock M, Garcia G, et al. H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12. J Allergy Clin Immunol. 2007;120(4):827-834. [46] Melief SM, Zwaginga JJ, Fibbe WE, et al. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med. 2013;2(6):455-463. [47] Kim KS, Kim HS, Park JM, et al. Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model. Neurobiol Aging. 2013;34(10): 2408-20. [48] Liu D, Xu J, Liu O, et al. Mesenchymal stem cells derived from inflamed periodontal ligaments exhibit impaired immunomodulation. J Clin Periodontol. 2012;39:1174-1182. [49] Liu Y, Wang L, Kikuiri T, et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α. Nat Med. 2011;17:1594-1601. [50] Vanella L, Kim D H, Sodhi K, Barbagallo I, Burgess AP, Falck JR, Schwartzman ML, Abraham NG. Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes. Prostaglandins Other Lipid Mediat. 2011;96(1):54-62. [51] Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature. 2003;15; 423(6937): 349-355. [52] Zhu XB, Lin WJ, Lv C, et al. MicroRNA-539 promotes osteoblast proliferation and differentiation and osteoclast apoptosis through the AXNA-dependent Wnt signaling pathway in osteoporotic rats. J Cell Biochem. 2018 Jun 12. [53] Bao Y, Gao Y, Du M, et al. opical Treatment with Xiaozheng Zhitong Paste (XZP) Alleviates Bone Destruction and Bone Cancer Pain in a Rat Model of Prostate Cancer-Induced Bone Pain by Modulating the RANKL/RANK/OPG Signaling. Evid Based Complement Alternat Med. 2015;2015:215892. [54] Rangaswami H, Schwappacher R, Tran T, et al. Protein kinase G and focal adhesion kinase converge on Src/Akt/ β-catenin signaling module in osteoblast mechanotransduction. J Biol Chem. 2012;287(25): 21509-21519. [55] Liang D, Yang M, Guo B, et al. Zinc inhibits H(2)O(2)-induced MC3T3-E1 cells apoptosis via MAPK and PI3K/AKT pathways. Biol Trace Elem Res. 2012;148(3):420-429. [56] Oni-Orisan A, Deng Y, Schuck RN, et al. Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice. Prostaglandins Other Lipid Mediat. 2013;104-105:67-73. [57] Wang H, Lin L, Jiang J, et al. Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways. J Pharmacol Exp Ther. 2003; 307(2):753–764. [58] Abraham NG, Sodhi K, Silvis AM, et al. CYP2J2 targeting to endothelial cells attenuates adiposity and Vascular Dysfunction in Mice Fed a High-Fat Diet by Reprogramming Adipocyte Phenotype. Hypertension. 2014;64(6):1352–1361. [59] Duflot T, Roche C, Lamoureux F, et al. Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases. Expert Opin Drug Discov. 2014;9(3): 229-243. [60] Lazaar AL, Yang L, Boardley RL, et al. Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor. Br J Clin Pharmacol. 2016;81(5):971-979. [61] Chen D, Whitcomb R, MacIntyre E, et al. Pharmacokinetics and pharmacodynamics of AR9281, an inhibitor of soluble epoxide hydrolase, in single- and multiple-dose studies in healthy human subjects. J Clin Pharmacol. 2012;52(3): 319-328. [62] Bellien J, Iacob M, Remy-Jouet I, et al. Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension. Circulation. 2012;125(10):1266-1275. [63] Noonan JE, Dusting GJ, Nguyen TT, et al. Flicker light-induced retinal vasodilation is unaffected by inhibition of epoxyeicosatrienoic acids and prostaglandins in humans. Invest Ophthalmol Vis Sci. 2014;55(10):7007-7013. [64] Liu JY, Park SH, Morisseau C, et al. Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo. Mol Cancer Ther. 2009;8(8):2193-2203. [65] Kim JH, Cho CW, Tai BH, et al. Soluble Epoxide Hydrolase Inhibitory Activity of Selaginellin Derivatives from Selaginella tamariscina. Molecules. 2015;20(12):21405-21414. [66] Kitamura S, Morisseau C, Inceoglu B, et al. Potent natural soluble epoxide hydrolase inhibitors from Pentadiplandra brazzeana baillon: synthesis, quantification, and measurement of biological activities in vitro and in vivo. PLoS One. 2015;6:10(2):e0117438. [67] Bai MM, Shi W, Tian JM, et al. Soluble epoxide hydrolase inhibitory and anti-inflammatory components from the leaves of Eucommia ulmoides Oliver (duzhong). J Agric Food Chem. 2015;63(8):2198-2205. [68] Sun YN, Li W, Song SB, et al. A new phenolic derivative with soluble epoxide hydrolase and nuclear factor-kappaB inhibitory activity from the aqueous extract of Acacia catechu. Nat Prod Res. 2016;30(18):2085-2092. [69] Sun YN,Kim JH,Li W,et al. Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe. Bioorg Med Chem. 2015;23(20):6659-6665. |